FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2922388035> ?p ?o ?g. }

• W2922388035 abstract "An increase in xanthine oxidoreductase (XOR) activity is related to various diseases such as diabetes, hypertension and obesity has been reported. However, so far the association with XOR activity and pathogenesis of atherosclerosis in a general Japanese population are not known. The purpose of this study is to investigate the association between XOR activity and progression of atherosclerosis including pulse wave velocity (PWV) and flow mediated dilation (FMD) in a general Japanese population. The Iwate Tohoku Medical Megabank Organization pooled individual participant data from a general population-based cohort study in Iwate prefecture (n = 810, male / female = 271 / 539, age = 67.6 ± 7.2). Plasma levels of XOR activity in males were marginally higher than in females (89.6 ± 187.0 vs. 64.8 ± 145.8 pmol / h/ mL, p = 0.06). Arterial stiffness by PWV after log10 transformation was significantly higher in quartiles III and IV of XOR compared to quartiles I in females (F =4.768, p < 0.01) (quartiles I vs. III, 3.187 ± 0.088 vs. 3.214 ± 0.081, p < 0.01; quartiles I vs. IV, 3.187 ± 0.088 vs. 3.213 ± 0.080, p < 0.05). Endothelial function as assessed by FMD was significantly lower in quartiles III and IV compared to quartiles I in females (F = 6.074, p < 0.001) (quartiles I vs. III, 6.02 ± 3.19 vs. 4.90 ± 2.66 %, p < 0.01; quartiles I vs. IV, 6.02 ± 3.19 vs. 5.04 ± 2.76 %, p < 0.01). XOR activity was related to progression of atherosclerosis (FMD, OR = 0.930, p = 0.06) and the high risk for CVD in females (Suita Score ≥ 41, OR = 1.92, 95% confidence interval (CI) = 1.04 - 3.54, p < 0.05). XOR activity was no significant association with progression of atherosclerosis and the high risk for CVD in males. The area under the curve (AUC) for XOR activity combined with Suita score was 0.66 (95% CI = 0.52 - 0.77, p < 0.05). In conclusion, XOR activity is associated with endothelial dysfunction and increased arterial stiffness suggesting that elevated XOR activity may relate to progression of atherosclerosis and indicate the CV risk." @default.
• W2922388035 created "2019-03-22" @default.
• W2922388035 creator A5000872442 @default.
• W2922388035 creator A5010916869 @default.
• W2922388035 creator A5012393967 @default.
• W2922388035 creator A5027776738 @default.
• W2922388035 creator A5039000820 @default.
• W2922388035 creator A5050653918 @default.
• W2922388035 creator A5055814626 @default.
• W2922388035 creator A5070727836 @default.
• W2922388035 creator A5074935056 @default.
• W2922388035 creator A5080876255 @default.
• W2922388035 date "2019-03-05" @default.
• W2922388035 modified "2023-09-26" @default.
• W2922388035 title "Abstract P031: Plasma Xanthine Oxidoreductase Activity is Associated With Edothelial Dysfucntion and Increased Arterial Stiffness in a General Japanese Population: the Iwate Tohoku Medical Megabank Project" @default.
• W2922388035 doi "https://doi.org/10.1161/circ.139.suppl_1.p031" @default.
• W2922388035 hasPublicationYear "2019" @default.
• W2922388035 type Work @default.
• W2922388035 sameAs 2922388035 @default.
• W2922388035 citedByCount "0" @default.
• W2922388035 crossrefType "journal-article" @default.
• W2922388035 hasAuthorship W2922388035A5000872442 @default.
• W2922388035 hasAuthorship W2922388035A5010916869 @default.
• W2922388035 hasAuthorship W2922388035A5012393967 @default.
• W2922388035 hasAuthorship W2922388035A5027776738 @default.
• W2922388035 hasAuthorship W2922388035A5039000820 @default.
• W2922388035 hasAuthorship W2922388035A5050653918 @default.
• W2922388035 hasAuthorship W2922388035A5055814626 @default.
• W2922388035 hasAuthorship W2922388035A5070727836 @default.
• W2922388035 hasAuthorship W2922388035A5074935056 @default.
• W2922388035 hasAuthorship W2922388035A5080876255 @default.
• W2922388035 hasConcept C126322002 @default.
• W2922388035 hasConcept C134018914 @default.
• W2922388035 hasConcept C164705383 @default.
• W2922388035 hasConcept C2775850156 @default.
• W2922388035 hasConcept C2778319312 @default.
• W2922388035 hasConcept C2908647359 @default.
• W2922388035 hasConcept C44249647 @default.
• W2922388035 hasConcept C68443243 @default.
• W2922388035 hasConcept C71924100 @default.
• W2922388035 hasConcept C84393581 @default.
• W2922388035 hasConcept C90924648 @default.
• W2922388035 hasConcept C99454951 @default.
• W2922388035 hasConceptScore W2922388035C126322002 @default.
• W2922388035 hasConceptScore W2922388035C134018914 @default.
• W2922388035 hasConceptScore W2922388035C164705383 @default.
• W2922388035 hasConceptScore W2922388035C2775850156 @default.
• W2922388035 hasConceptScore W2922388035C2778319312 @default.
• W2922388035 hasConceptScore W2922388035C2908647359 @default.
• W2922388035 hasConceptScore W2922388035C44249647 @default.
• W2922388035 hasConceptScore W2922388035C68443243 @default.
• W2922388035 hasConceptScore W2922388035C71924100 @default.
• W2922388035 hasConceptScore W2922388035C84393581 @default.
• W2922388035 hasConceptScore W2922388035C90924648 @default.
• W2922388035 hasConceptScore W2922388035C99454951 @default.
• W2922388035 hasIssue "Suppl_1" @default.
• W2922388035 hasLocation W29223880351 @default.
• W2922388035 hasOpenAccess W2922388035 @default.
• W2922388035 hasPrimaryLocation W29223880351 @default.
• W2922388035 hasRelatedWork W1976056755 @default.
• W2922388035 hasRelatedWork W2047313477 @default.
• W2922388035 hasRelatedWork W2078297210 @default.
• W2922388035 hasRelatedWork W2111578065 @default.
• W2922388035 hasRelatedWork W2119148367 @default.
• W2922388035 hasRelatedWork W2520665261 @default.
• W2922388035 hasRelatedWork W2756420142 @default.
• W2922388035 hasRelatedWork W2899489693 @default.
• W2922388035 hasRelatedWork W3213422583 @default.
• W2922388035 hasRelatedWork W4286916783 @default.
• W2922388035 hasVolume "139" @default.
• W2922388035 isParatext "false" @default.
• W2922388035 isRetracted "false" @default.
• W2922388035 magId "2922388035" @default.
• W2922388035 workType "article" @default.